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applied in a rural district in Mexico. Identify barriers to be con-
sidered in its implementation. METHODS: Cost Study: A pilot
cross-sectional, multicenter case study was conducted in 2001 in
Sanitary District No. III, State of Morelos, Mexico. A general
hospital, an urban health centre and two rural health centres, all
managed by the Ministry of Health, were selected. The Mother-
Baby Package Costing Spreadsheet was used to estimate the total
cost and cost by intervention under the current model and
Mother-Baby Package model. Qualitative Study: Key informants
from the hospital, the urban centre and eight rural health centres
were interviewed. The “3 Delays Model” was used to identify
barriers to be considered. RESULTS: The total cost of the
Mother-Baby Package is twice the cost of the current child and
maternal health care model in Morelos, Mexico. Of the 18 inter-
ventions evaluated, those consuming the highest proportion of
total costs were antenatal-care and normal-delivery. Personnel
costs represent more than half of total costs. Barriers identiﬁed
were machismo, culture and the negative perception of health
centres amongst users (causing delay in deciding to seek care),
difﬁculty obtaining transportation in emergency situations (gen-
erating delay in reaching a ﬁrst referral level facility); and short-
age of drugs, adequate equipment and trained staff (causing
delay in receiving care after arriving at the facility). CONCLU-
SIONS: Improving the delivery of child and maternal health care
in a poor setting in accordance with the Mother-Baby Package
standards would require a budget two times that which is cur-
rently assigned to these services. However, before implementing
a scaled-up version of the package it would be essential to
manage problems that appear to be barriers that exist in pro-
viding and accessing appropriate maternal and child health care.
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OBJECTIVES: To assess the clinimetric properties of the Spanish
version of the Self-Esteem And Relationship (SEAR) question-
naire to be used in Spain with patients with ED. METHODS:
The SEAR questionnaire comprises 14 items divided into two
domains: Sexual Relationship (8 items) and Conﬁdence (6 items),
the latter comprising Self-Esteem (4 items) and Overall Rela-
tionship (2 items). The USA-English-version of SEAR question-
naire was adapted linguistically into Spanish by using forward
and back translation methods and a conceptual equivalence
approach. The SEAR questionnaire was administered to a group
of patients with ED (IIEF < 26) seven days before starting treat-
ment and at baseline and after three months of treatment (group
A), and to a group of healthy control subjects (IIEF ≥ 26) (group
B) in a single visit. SF-12 and HAD scales were also adminis-
tered. RESULTS: Out of 831 recruited subjects (n = 732, group
A; n = 99, group B), 559 subjects were included as evaluable for
validation analysis (n = 504, group A; n = 55, group B). The per-
centage of patients without response was < 5% for all domains.
Cronbach’s Alpha coefﬁcient was 0.92 and 0.86 in groups A and
B. The SEAR questionnaire discriminated between patients and
controls (area under curve = 0.999) and groups of patients by
severity of ED (Kruskall-Wallis test: p < 0.0001). Correlation was
high with Erectile Function scale of IIEF (r = 0.69) and moder-
ate with HAD (r = -0.41) and SF-12 Mental Health (r = 0.38).
The SEAR questionnaire also showed responsiveness with
improvement in scores from start to end of treatment (Mann-
Whitney-Wilcoxon test: p < 0.0001). CONCLUSIONS: The
SEAR questionnaire showed adequate feasibility, reliability,
validity and responsiveness for its use for measuring the emo-
tional tension and relationship difﬁculties associated with erec-
tile dysfunction.
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OBJECTIVES: Assisted Reproduction is among the fastest
growing areas of medicine, rising debates about ﬁnancing in vitro
fertilisation (IVF) or other assisted reproductive techniques by
national third party payer. This study describes policies of infer-
tility treatment as well as willingness to pay for treatment in
affected couples in Germany (contribution-ﬁnanced health care
system) and the U.K. (tax-ﬁnanced health care system).
METHODS: Literature review with the key words: infertility,
willingness to pay, epidemiology. For assessment of national
reimbursement policies, websites of the respective health care
institutions were reviewed. RESULTS: In 2001, over 25,000 IVF
treatment cycles were carried out in Great Britain, 25% being
funded by the National Health Service. New clinical guidelines
accepted by the Department of Health, assure that from 2005,
more assisted reproduction services are covered by the NHS,
such as one full cycle of IVF. Over 2/3 of the patients currently
paying privately are expected to demand for NHS services result-
ing in an enormous increase in IVF treatment. In Germany, about
75,000 treatments were performed in 2001. Since January 2004,
German statutory sick funds restricted reimbursement to 50%
of the costs for the ﬁrst three IVF treatment cycles. Due to these
regulations, changes in treatment patterns for IVF can be
expected for the future. An ongoing online-questioning revealed
that for only 60%, the decision for IVF treatment remained
unchanged, whereas the rest either postponed the decision or
cancelled IVF. Two studies (USA, Sweden) revealed the willing-
ness to pay of infertile couples to be 14,500€ or more. CON-
CLUSIONS: Contradictory dynamics between willingness to pay
and change of mind due to restrictive reimbursement policies
show need for more research in the ﬁeld of infertility treatment.
Economic and social consequences of changing frame conditions
for IVF should be closely assessed, to ensure high quality of life
for affected couples.
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OBJECTIVES: Adaptation and validation of measures of short-
term and long-term consequences of false positive screening-
mammography. METHODS: After translation (including quality
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control) of the PCQ it was presented in six focus groups (5–7
women) and in 15 telephone interviews. All interviewees had
previously experienced false positive screening-mammography.
Validation-I: Six hundred women completed the short-term ques-
tionnaire together with the Danish version of the Nottingham
Health Proﬁle (NHP). One-third had had abnormal and two-
thirds had had normal screening-mammography. Validation-II:
One hundred twenty-seventy women who had had false positive
screening mammography up to 6 months ago, and 197 women
with normal mammography completed the long-term question-
naire. Data were analysed using traditional psychometric theo-
ries and Item Response Theories. RESULTS: None of the PCQ
items were found irrelevant. The interviewees, however, found
that not all consequences of false positive screening-mammog-
raphy were covered by the PCQ. Twenty-eight items were gen-
erated (including splitting of double-barrelled item) and it was
decided to divide the questionnaire into 2, 1 measuring short-
term and another long-term consequences. Both questionnaires
were found to be reliable with Cronbach’s Alpha 0.95 and 0.90.
Validation-I: 4 strongly correlated dimensions (24 items in total)
were found to be in order and additive, 4 single items were kept
because of high face validity and ﬁve “bad” items (including one
of the original PCQ items) were deleted. Results on Know Group
Validity and Concurrent Validity (i.e. correlation with the 6 NHP
sections) conﬁrming the a priori hypothesis will be presented at
the conference. Validation-II: No bad items were identiﬁed.
Three strongly correlated dimensions (13 items in total) were
found to be in order and additive. CONCLUSIONS: Two 
reliable and valid instruments, one on short-term and one on
long-term psychosocial consequence of false positive screening-
mammography have been developed and are currently under
adaptation into Norwegian and English.
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OBJECTIVES: To assess the prevalence, health resources usage
(HRU) and cost of Vascular Dementia (VD) in comparison with
that of the Alzheimer Disease (AD) in a population setting in
Spain. There few data available on HRU and cost of VD, and
no information is available in Spain. It is estimated that eco-
nomic impact of VD may be even higher than AD. METHODS:
A cross-sectional & retrospective, observational study with two
phases was designed. In 1st phase, patients with diagnosis of
dementia were selected from a database claim. During 2nd
phase, a clinic evaluation, including administration of Mini-
Mental State Examination, was performed along with data col-
lection on HRU. Direct costs were estimated by sum of HRU
during last 6 months. Also, caregiver burden was determined by
counting the time dedicated to patient care. Descriptive statis-
tics, regression models and bootstrap techniques were used.
RESULTS: A total of 6004 claims were reviewed, of whom 224
out of 258 with dementia fulﬁlled criteria of VD or AD diag-
nostic. Subjects with mixed dementia were excluded from the
analysis. Total prevalence was 4.3% in population above 64
years old and increased with ageing; 64.3% was of AD type, and
28.1% of VD. The total cost of dementia per patient per a 6-
month-period was signiﬁcantly higher for VD than for AD;
10.316€ versus 8.209€, p < 0.05. The proportion of cost attrib-
utable to caregivers was the main component of burden in both
types; 85.5% in AD versus 84.4% in VD. CONCLUSIONS:
Prevalence of dementia increases with ageing, although no socio-
demographics differences could be identiﬁed. Health care costs
are substantial for this disorder, particularly for VD in compar-
ison with AD. Cardiovascular risks prevention in VD should be
associated to a positive impact in health care resources utiliza-
tion for this dementia.
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OBJECTIVES: Assess value of admission stroke severity in pre-
dicting outcomes at discharge for patients with ﬁrst-ever
ischemic stroke in Taiwan. METHODS: Data was prospectively
collected from 360 ﬁrst-ever ischemic stroke patients consecu-
tively admitted to a medical center. Stroke severity was evaluated
with NIH stroke scale (NIHSS) and categorized as mild (0–6),
moderate (7–15), or severe (16–38). Functional independence
status was accessed by modiﬁed Barthel Index (MBI) on a scale
of 0–20. We studied three discharge outcomes: 1) status based
on combined measure of neurological impairment and disability
(excellent, good, improved, poor); 2) neurologic changes (better,
stationary, worse); and 3) functional changes (better, stationary,
worse). For each outcome, a separate polytomous logistic regres-
sion model with least favorable category as the reference group
was constructed, controlling confounding factors. RESULTS:
Patients (58% male) had mean age 64.9 ± 12.7 (range 18–93),
median NIHSS 6 and median MBI 12 on admission. Median
length-of-stay was 7 (range, 1–122) days; in-hospital deaths 8%.
Twenty-two percent (22%) of patients were excellent status
(NIHSS £1 and MBI ≥19), 33% good (NIHSS £6 and MBI ≥12
but not excellent). Twenty-two percent (22%) of patients had
better neurologic change (decrease on NIHSS ≥4), 61% station-
ary (NIHSS changed within ±3); functional change, 14% better
(MBI changed from < 12 to ≥12), 75% stationary (MBI remained
< 12 or ≥12). The odds ratio (OR) for moderate and severe
(versus mild) stroke patients to achieve excellent status were 0.04
(95% CI, 0.02–0.10) and < 0.01, respectively. The OR for mod-
erate stroke patients to have good or improved outcome was
0.19 (0.10–0.36), for severe stroke 0.04 (0.01–0.13). The OR
for moderate and severe (versus mild) stroke patients to have
better neurologic change were 5.18 (1.94–13.85) and 4.12
(1.38–12.30), respectively. CONCLUSIONS: Admission NIHSS
is predictive of clinical outcomes of acute hospitalization after
ﬁrst-ever ischemic stroke.
